Zenith Drugs Wins ₹25 Million Tender, Enhancing Market Share

Zenith Drugs Ltd, a newly listed pharmaceutical firm, has made the announcement of winning a large tender of ₹25 million. This comes barely a few weeks after the firm's successful Initial Public Offering  in February 2024. The tender will enhance Zenith's market share and add to its revenue base. The firm, which has produced more than 250 molecules and 780 dosage forms, will most probably use its WHO-GMP certified plant in Indore to complete this order. The agreement is part of Zenith's plans to upgrade current units and install new plants. The victory in the tender is an indicator of the increasing competitiveness of the firm in the pharma business and capacity to win big orders. 
Source: Business Standard